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ABSTRACT
G-quadruplex nucleic acids have been proposed to
play a role in a number of fundamental biological
processes that include transcription and translation.
We have developed a single-chain antibody that
is selective for G-quadruplex DNA over double-
stranded DNA, and here show that when it is
expressed in human cells, it significantly affects
the expression of a wide variety of genes, in a
manner that correlates with the presence of pre-
dicted G-quadruplexes. We observe cases where
gene expression is increased or decreased,
and that there are apparent interactions with
G-quadruplex motifs at the beginning and end of
the genes, and on either strand. The outcomes
of this genome-wide study demonstrate that
G-quadruplex recognition by the antibody has phys-
iological consequences, and provides insights
into some of the complexity associated with
G-quadruplex-based regulation.
INTRODUCTION
G-quadruplexes are highly stable alternative DNA
structures formed by tetrads of guanines that interact via
Hoogsteen hydrogen bonds and are stabilized by
monovalent cations (1–4). A number of conformationally
diverse G-quadruplex structures have been determined by
NMR or X-ray crystallography (5–8). G-quadruplexes
have been shown to occur at telomeres (9,10), and have
potential as a target class for therapeutics (11–13).
Algorithms have been developed to predict which
genomic sequences will form G-quadruplexes (14),
and many have been predicted to form in gene
promoters (15), a number of which have been the
subject of detailed investigation (16). These include
oncogenes such as c-myc (17), c-kit (18,19) and k-ras
(20), where G-quadruplex formation has been shown to
control gene transcription levels. Further support for the
G-quadruplex-promoter hypothesis has been provided by
genomic studies which have shown a link between the
presence of a G-quadruplex motif and expression levels
of the associated genes (21). The detailed molecular mech-
anism(s) by which DNA G-quadruplexes could inﬂuence
gene expression is the subject of investigation by a number
of research groups. One model is that G-quadruplex for-
mation interferes with protein-DNA interactions (22).
However, it is also conceivable that more than one
G-quadruplex-related mechanism may operate, depending
on the speciﬁc gene in question. There is evidence that
gene expression can be perturbed by small molecules
(13,23) or proteins (24,25) that target G-quadruplex
nucleic acids, and indeed there are many natural
proteins that interact speciﬁcally with G-quadruplexes
(22), suggestive of natural G-quadruplex-related
mechanisms.
G-quadruplex DNA structures have been found
computationally in many positions in the genome consid-
ered to be of importance for gene regulation. For
promoter quadruplexes (i.e. near to the TSS), there are
numerous experimental studies on individual cases to
support their structure and formation in vitro (3,8,26–28)
and that their formation may inﬂuence gene regulation in
cells (17,20,29).
Recent attempts to elucidate the biological function of
DNA G-quadruplexes in promoter regions have been
focused on the use of small molecule ligands, selected
for their ability to bind and stabilize or disrupt these
structures (20,29,30). There have been experiments
described in the literature that demonstrated either
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in gene expression by a G-quadruplex binding small
molecule (32,33). We have previously shown that artiﬁcial
proteins that recognize G-quadruplex DNA with
nanomolar aﬃnity can be selected using phage display
of libraries of zinc ﬁngers (24,34,35) and more recently
using single-chain antibody libraries (25). In the current
work, we have employed a single-chain G-quadruplex
binding antibody (HF1) that was selected from a phage
library by methods analogous to those used previously
(25), but with negative selection against only duplex
DNA. Antibody HF1 shows broad aﬃnity to a range of
DNA G-quadruplexes that we had selected from the
promoters of various genes: ckit2, Kd=54nM; GRINA,
Kd=4.5mM; AGRN, Kd=300nM; SPIN1, Kd=16mM;
ASPSCR1, Kd=23mM (see ‘Materials and Methods’
section and Table 1 of Supplementary Data for details).
In contrast, HF1 shows no detectable binding to double
stranded DNA (dsDNA, Supplementary Table S1). As
such, it represents a highly structure-speciﬁc tool, which
can be used to probe the presence and function of
G-quadruplexes within the genome. Binding events
of the antibody to G-quadruplexes located in pro-
moters might be expected to interfere with the regulatory
mechanism and result in changes of the levels of gene
expression of those genes containing a quadruplex in
their promoter. We therefore conducted a genome-wide
expression study to test the promoter hypothesis in
human cells in which we have exogenously expressed
antibody HF1.
In addition to promoter-speciﬁc eﬀects, we also sought
to investigate other eﬀects that this antibody may have.
In particular, we observed eﬀects either side of the site of
transcriptional termination. These experimental data are
in line with predictions made in our recent computational
study, which suggested the possible involvement of
G-quadruplexes in transcription termination (36).
MATERIALS AND METHODS
Selection and cloning of the scFv antibody
The single-chain antibody HF1 was selected from the
Tomlinson J phage library by screening against the
biotinylated c-Kit 2 G-quadruplex sequence immobilized
onto streptavidin-coated immunotubes as described in ref.
(25) with the alteration that three rounds of panning were
performed and duplex DNA was used as the competitor.
The DNA sequence was then PCR ampliﬁed from the
parental pIT2 vector using the primers ‘pIT2 fwd PCR’:
50-CATGTATACCTGCGCGCGGAGGTGCAGCTGTTG-30
and ‘pIT2 rev PCR’:
50-GCAGAATTCTCAATTCAGATCCTCTTCTGAGAT- 30.
The scFv coding DNA was inserted into the mamma-
lian expression vector construct pIRES2-EGFP
(Clontech) by using the restriction sites BssHII and
EcoRI and adding a nuclear localization sequence
(NLS), which were appended to the DNA encoding the
scFv using PCR ampliﬁcation from the phagemid.
Sequencing results conﬁrmed integrity of the resulting
construct (Supplementary Figure S2), and ﬂuorescence
microscopy of a NLS-HF1-EGFP fusion construct con-
ﬁrmed the nuclear localization of the scFv (Supplementary
Figure S3).
Expression of scFv and ELISA against G-quadruplexes
Expression of the soluble scFv was performed as described
in ref. (25). We carried out ELISA measurements, as
described in ref. (25), to determine the Kd of HF1
against a range of promoter derived G-quadruplexes:
ckit2 (50 GAC CCG GGC GGG CGC GAG GGA
GGG GAG G 30); GRINA (50 CGA GGG GTG GGG
TCG GGC GGT GGG CGC 30); AGRN (50 CTC CGG
GCG GGC CGG GGG AGG GAG GAG GGA GGG
GGC GGG AGG GGG AAG 30); SPIN1 (50 CAG TGG
GGC GGG GCG GGG CCG GCG AGG GCG GGG
CCT 30); ASPSCR1 (50 CCA AGG GCG GGG CCG
GGG CGC CGT GGG TGG GGA AAG GGC GGG
GCC T 30) (Supplementary Table S1).
Transfection of mammalian cells
We employed human gastric carcinoma cells HGC-27, for
their good general handling qualities and ease of
transfection. Transient transfections of HGC-27 were
done in T-75 ﬂasks using Lipofectamine2000 transfection
reagent (Invitrogen), using 12ml of cells at a density of
1 10
5cells/ml grown overnight. Thirty micrograms of
Table 1. PQS densities, and proportions of genes with a PQS, in four genomic regions: 200bp before the TSS (‘promoter region’), 200bp after the
TSS (‘Beginning of the gene’), 100bp before the TES (‘End of the gene’) and 100bp after the end of the TES (‘After the gene’)
Gene type All genes Diﬀerentially expressed genes Upregulated genes Downregulated genes
Strand Both Coding Template Both Coding Template Both Coding Template Both Coding Template
PQS density
(# per kb)
Promoter region 1.48 0.74 0.74 1.81 0.90 0.91 1.98 1.03 0.95 1.61 0.75 0.86
Beginning of the gene 0.99 0.57 0.42 1.32 0.72 0.60 1.40 0.76 0.64 1.23 0.68 0.55
End of the gene 0.18 0.08 0.10 0.28 0.10 0.19 0.42 0.14 0.28 0.11 0.04 0.08
After the gene 0.30 0.21 0.09 0.50 0.39 0.11 0.50 0.37 0.13 0.49 0.42 0.08
Proportion
of genes
with a
PQS (%)
Promoter region 24.2 12.9 12.9 29.2 15.5 15.5 31.5 17.0 16.8 26.5 13.7 14.0
Beginning of the gene 17.7 10.6 7.8 23.0 13.1 11.1 24.3 13.6 11.8 21.5 12.5 10.2
End of the gene 1.8 0.8 1.0 2.8 1.0 1.9 4.1 1.4 2.8 1.1 0.4 0.8
After the gene 2.9 2.1 0.9 4.9 3.9 1.1 5.0 3.7 1.3 4.8 4.0 0.8
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pIRES-EGFP) and 75ml of transfection reagent were used
per T-75 ﬂask and transfected according to the manufac-
turer’s protocol in serum-free medium. Cells were
harvested 15h after transfection. The medium was
removed and the ﬂask was washed with 10ml 1  PBS
three times. Five ml Trypsin-EDTA solution was added
to the ﬂask and incubated at 37 C for 2–3min. When the
cells had dislodged from the ﬂask bottom, 20ml of
EMEM medium+10% FCS was added into the ﬂask to
stop trypsin digestion. The contents were gently mixed and
transferred into a 50ml Falcon tube. The tube was spun at
300g for 5min and resuspended in 10ml PBS. The cells
were spun again and resuspended in PBS containing 0.1%
FCS. The cell suspension was analysed FACS after the
addition of propidium iodide (to stain the non-viable
cells), and sorted to select for transfected cells.
RNA extraction
Flow sorted cells harboring the transfected plasmid were
used for total RNA extraction. Cells were disrupted with
QIAshredders and total RNA was isolated using the
RNeasy kit from Qiagen according to the manufacturers
instructions. Puriﬁed RNA was analysed at the Centre for
Microarray Resources at the Department of Pathology,
University of Cambridge.
Microarray data processing
Gene expression was proﬁled in triplicate (three
treatments, three controls) on an Illumina Human 6
version 2 BeadArray (37). The bead-level data were
analysed using the R beadarray package (38), including
image sharpening, local background subtraction, bead
summarization and quantile normalization between
arrays. Replicate 2J (HF1 treatment, array E) was found
to be an outlier and discarded from the analysis prior to
normalization. Diﬀerential expression was assessed
using the R limma package (39), taking into account
bead variances as weights, and using a corrected P-value
threshold of 0.001. We only considered probes
that mapped to genes that have an Ensembl gene id,
‘known’ and ‘protein coding’ status, using the R
biomaRt package (40) and the Illumina probe annotation
provided in Ensembl. When multiple probes mapped to a
single gene, only the probe with the lowest corrected
P-value was kept. The Ensembl annotation was used to
deﬁne the transcription start site (TSS) and end site of
each gene.
Identiﬁcation of PQS
Putative quadruplex sequences (PQS) were identiﬁed
in the human genome (NCBI 36) using the quadparser
algorithm (14), which is available online at http://
www.quadruplex.org/?view=quadparser. Brieﬂy, we
used the default parameters for this program, which
searches for sequences of the form G3+N1–7G3+N1–7
G3+N1–7G3+ on either strand of the sequence given.
The PQS density distributions between diﬀerent groups
of genes were compared in diﬀerent regions, and the
signiﬁcance of those diﬀerences was assessed using a
two-sample t-test, allowing unequal variances. Control
sequences, such as those with only three GGG-repeats,
or that were A or T rich, did not produce equivalent
results (data not shown).
RESULTS AND DISCUSSION
The single-chain antibody HF1 was selected from the
Tomlinson J phage library as described in ‘Materials
and Methods’ section. The human cell line HGC-27 was
transfected with the plasmid encoding the gene for the
HF1 antibody under the control of a CMV promoter.
The parental vector pIRES2-EGFP, which lacked the
HF1 gene, was employed in a control transfection. The
expression levels were assessed by ﬂuorescence microscopy
and FACS analysis of the co-expressed EGFP. The levels
were in line with control data from a CMV promoter,
indicative of strong expression. For experiments using
both HF1 and the control, total RNA was extracted
15h after transfection (‘Materials and Methods’ section).
All transfections were done in triplicate and ﬂow sorted to
collect only the cells harboring the expression plasmid,
which also expressed EGFP. A sample of cDNA from
each triplicate was hybridized to a separate Illumina
Human 6 version 2 BeadArray. The microarray data
were analysed using the R packages beadarray and
limma (‘Materials and Methods’ section).
The analysis showed that of 18105 known protein-
coding genes, 1767 were signiﬁcantly diﬀerentially
expressed (DE) in the HF1 samples versus the control
samples, using a corrected P-value of 10
 3. Of these DE
genes, 973 (55%) were up-regulated compared with the
control, and the remaining 794 (45%) were down-
regulated.
The subject of our analysis was to investigate whether
the presence of putative G-quadruplex sequences (PQS) in
regulatory regions was related to the diﬀerential expres-
sion of genes. The principal region of study was a window
200bp either side of the TSS, which is involved in tran-
scription initiation. We also considered the 100bp region
either side of the transcription end site (TES), to explore
regulatory eﬀects that may be associated with transcrip-
tion termination (36). In our analysis, we elected to limit
the ranges for each of these regions (Figures 1 and 2),
to capture most of the deviations of interest, without
including too many distal sequences that would add to
the noise in the data (for an analysis of genomic regions
not considered here Supplementary Figure S1). Previous
results have shown that these regions contain peaks in
incidental G-quadruplex density (15,36). A single base-
pair resolution analysis of the PQS densities did not
yield additional insights compared with the region-level
analysis. Of note for comparative purposes, the previously
calculated density of PQS in the whole genome is 0.115
and 0.153PQS/kbase when considering only the fraction
of DNA that is ever transcribed as pre-mRNA.
Promoter region—200bp upstream of the TSS
The promoter region of genes is known to have a high
PQS density compared with other regions of the human
6718 Nucleic Acids Research, 2009,Vol.37, No. 20genome (15). In our experiment, we found that the
promoters of diﬀerentially expressed (DE) genes were
signiﬁcantly enriched in PQS compared with all genes
(1.81 PQS/kb compared with 1.48 PQS/kb, a 22% enrich-
ment, P=3 10
 6 using a two-sample t-test) (full details
in Table 1; graphical representations in Figure 1).
This enrichment was higher for up-regulated genes
(1.98PQS/kb) compared with down-regulated genes
(1.61PQS/kb) (signiﬁcant diﬀerence, P=0.01). There
was no signiﬁcant strand asymmetry; G-quadruplexes
located on the coding and template strands were equiva-
lent (at signiﬁcance level 0.05).
Beginning of the gene—200bp downstream of the TSS
We then considered the ﬁrst 200bp of each gene tran-
script, and found broadly similar results to those
obtained for the 200bp upstream of the TSS, but at gen-
erally lower PQS densities. DE gene were enriched in PQS
in this region (1.32PQS/kb for DE genes, compared
with 0.99PQS/kb for all genes, a 33% enrichment,
P=6 10
 9). There was a slight excess of enrichment
for up-regulated genes (1.40PQS/kb) as compared with
down-regulated genes (1.23PQS/kb), although this was
not statistically signiﬁcant at the 0.05 level. No signiﬁcant
strand asymmetry was observed.
These results show clearly that both upstream and
downstream of the TSS, diﬀerentially expressed genes
are signiﬁcantly enriched for PQS, even when taking
into consideration the general enrichment of PQS
proximal to the TSS for genes. This is consistent with
previous studies of these regions that showed they are
important for regulation of gene expression (15,17–
21,41). Whilst we cannot rule out the existence of cases
where a G-quadruplex on the template strand causes an
eﬀect via an RNA quadruplex, the strand symmetry
suggests the major eﬀect is at the DNA level. These
results are consistent with a direct interaction between
HF1 with DNA G-quadruplexes that changes the level
of expression of the adjacent gene. The data indicate
that the antibody acts preferentially on genes that
contain a PQS in the promoter sequence. This ﬁnding
is in line with the hypothesis that DNA promoter
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Collectively, these data suggest that G-quadruplexes on
either strand, upstream or downstram of the TSS can
have a regulatory eﬀect which can lead to up- or down-
regulation.
End of the gene—100bp upstream of the TES
The last 100bp of each gene has a fairly low density of
PQS, but DE genes showed signiﬁcant PQS enrichment
patterns there. Only 1.8% of all genes had a PQS in this
region (i.e. a density of 0.18PQS/kb), whereas 2.8% of DE
genes (a density of 0.28PQS/kb) had a PQS in this region,
giving an enrichment of 56% (P=6 10
 3). In relative
terms, this enrichment was much larger than in the
promoter region. Intriguingly, this enrichment appeared
to be conﬁned to up-regulated genes, with four times as
many genes with a PQS in this region being up-regulated
(40 genes) as compared with down-regulated (nine genes).
The PQS density in this region for up-regulated genes
was 0.42PQS/kb, compared with 0.11PQS/kb for
down-regulated genes, and 0.18 PQS/kb for all genes
(P=5 10
 5 comparing up-regulated genes to down-
regulated genes). PQS were more likely to be found on
the template strand in this region than on the coding
strand, when analysing all genes, (30% excess, P=0.02),
but among diﬀerentially expressed genes this became a
90% excess (1% of coding, versus 1.9% of template
strands contain a PQS).
After the gene—100bp downstream of the TES
The ﬁrst 100bp after the end of the gene is another region
with relatively low PQS density but striking enrichment
patterns. However, 5.0% of DE genes, as compared with
only 3.0% of all genes, had a PQS in this region, an
enrichment of 68%. The PQS density in this region
for DE genes was higher at 0.50PQS/kbase, as com-
pared with 0.30PQS/kb for all genes (P=5 10
 5).
In contrast to the last 100bp of the gene, PQS were
much more common here on the coding strand than the
template strand in all genes, with densities of 0.21 and
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 20). DE genes
showed an even greater strand bias, with densities of
0.39 and 0.11PQS/kb, respectively (P=3 10
 5 for the
coding strand). For down-regulated genes, the PQS
density on the coding strand was 0.42PQS/kb, whereas
the template strand had a density of only 0.08PQS/kb,
which was even lower than that for all genes.
We considered PQS at the 30-end of the gene because of
the proposed involvement of this region in transcription
termination (36). PQS are relatively rare in this region,
however, the signiﬁcant enrichment of PQS apparent in
diﬀerentially expressed genes in both of these regions
is clear and suggestive of an interaction of HF1 with
quadruplexes. A previous study on quadruplexes in
UTRs had also shown a marked increase in overall PQS
frequencies immediately after the end of genes (36). This
was determined computationally, based purely on
sequence identity. Our genome-wide data support a role
of G-quadruplexes in molecular mechanisms occurring at
the end of genes. As termination of transcription is a ﬁnely
regulated process and closely linked to initiation of tran-
scription (42), interfering at this stage of gene expression
could give rise to altered mRNA levels, as is manifest here.
Strand bias of PQS density around the TES
An interesting observation is the marked asymmetry in
PQS frequencies between both DNA strands at very
localized regions at the end of genes. In up-regulated
genes, our results show particularly high levels of PQS
enrichment in the template strand just before the end of
the gene. This PQS density drops greatly in sequences just
30-end of the gene (Figure 2B).
In down-regulated genes, the distribution of PQS shows
an inverse trend as compared with up-regulated genes.
Within the last 100bp of the UTR, the density of PQS is
less than the average across all genes. This is reversed
immediately after the end of the gene, where the PQS
density rises above average in the coding strand
(Figure 2D). This marked asymmetry of PQS density
with regards to both the strand as well as the position
relative to the end of the gene is striking and provides
evidence that the eﬀects of quadruplexes are highly depen-
dent on the precise location within the genome. The fact
that both up- and down-regulation can be observed
indicates that G-quadruplexes are part of a bona ﬁde reg-
ulatory system.
In our analysis, we have not factored in that some
diﬀerentially expressed genes might aﬀect the expression
of others, for example by acting as transcription factors to
genes genetically downstream. Such downstream genes
would, in principle, be aﬀected independently of the
presence of PQS in their vicinity, causing an apparent
dilution of any quadruplex-speciﬁc trends. Indeed, it is
known that transcription factors are more likely to have
PQS in their promoters than other gene classes (15). Thus,
the 1767 diﬀerentially expressed genes include genes whose
expression levels are directly or indirectly aﬀected by HF1.
Therefore the levels of enrichment we report are likely
to be an underestimate. While we have described the per-
turbation of gene expression by the quadruplex binding
protein HF1, we cannot on the basis of these data alone
unequivocally deﬁne the explicit role of the natural
quadruplex forming elements in the absence of HF1.
CONCLUSION
We have shown that an engineered G-quadruplex binding
antibody can have an eﬀect on gene expression in human
cells. The current genome-wide study reveals a correlation
between altered gene expression and the incidence of PQS
at either the promoter or the terminus of genes. Overall,
this genome-wide study supports the involvement of PQS
in gene regulation, whilst suggesting that the sense in
which G-quadruplex elements aﬀects gene expression
may well depend on the context of each quadruplex.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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